|
|
|
|
|
|
|
|
|
28.04.26 - 07:09
|
Iran-Krieg: DAX fest, Öl höher: Bayer, BP, DHL, Airbus, Telekom, Siemens, Rheinmetall, SAP im Fokus (Der Aktionaer)
|
|
|
Der DAX ist am Montag in die Verlustzone gedreht. Am Ende ging er mit einem Minus von 0,2 Prozent bei 24.083,53 Zählern aus dem Handel. Er setzte damit die Verlustserie aus der Vorwoche fort. Der Start in den Dienstag sieht etwas freundlicher aus. Der Broker IG taxiert den deutschen Leitindex am Morgen 0,2 Prozent höher auf 24....
|
|
|
|
|
|
|
23.04.26 - 08:06
|
Directorate change (Cision)
|
|
|
23 April 2026
Change to AstraZeneca Board of Directors
AstraZeneca congratulates Rene Haas on his appointment as Chief Executive Officer of SoftBank Group International, in addition to his position as Chief Executive Officer of Arm Holdings plc. Taking into account this additional workload, we have mutually agreed that Rene will not have enough time available to fully assume his AstraZeneca Board member duties. He will step down as a Non-Executive Director of AstraZeneca PLC on 30 April 2026, as he takes up his new appointment.
Michel Demaré, Chair of AstraZeneca, said "...
|
|
|
|
|
|
|
|
|
|
|
|
|
14.04.26 - 20:30
|
Ocumetics Technology Reports Attendance at ASCRS as Successful First-In-Human Trial Continues, No Material Change (The Newswire)
|
|
|
Key Highlights
No material change: There is no material change in the business affairs of Ocumetics.
Attendance at ASCRS: Productive ASCRS meetings with major global ophthalmic leaders.
Clinical and development momentum: Feedback supported positive results from the First-in-Human (FIH) Group 1 study while the Company advances toward Group 2 patient recruitment and upcoming surgeries.
Regulatory and commercialization pathway advancing: Discussions included FDA planning, market potential, and capital needs, with ongoing follow-up engagement planned with industry partners.
Calgary, Canada – April 14, 2026 - TheNewswire - Ocumetics Technology Corp. (TSV:V OTC |OTCQB: OTCFF |FRA: 2QBO) (“Ocumetics” or the “Company”), a leader in next generation ophthalmic technology, is pleased to report highly productive meetings held in Washington, D.C. during the recent American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting, where the Company engaged with industry leaders and s...
|
|
|
14.04.26 - 18:06
|
Otter Tail Corporation Announces President and CFO Transitions (Business Wire)
|
|
|
FERGUS FALLS, Minn.--(BUSINESS WIRE)--Otter Tail Corporation (Nasdaq: OTTR) today announced executive leadership transitions in conjunction with the long-term succession plan approved by its Board of Directors.
Effective April 13, 2026, Tim Rogelstad has been elected President of Otter Tail Corporation. In his new role, Mr. Rogelstad will oversee the electric and manufacturing platforms and report to Chuck MacFarlane, Otter Tail Corporation Chief Executive Officer.
Mr. Rogelstad previously served as President of Otter Tail Power Company, the Corporation's electric utility, and as Senior Vice President, Electric Platform of the Corporation.
Mr. Rogelstad has been with Otter Tail Power Company since 1989 and has held roles of increasing responsibility across the electric utility and the Corporation during his 37‑year career. He has served as the President of Otter Tail Power Company since 2014 and has been instrumental in advancing the Corporation's electric platform strategy and operational performance...
|
|
|
|
|
|
|
|
|
|
|
09.04.26 - 11:03
|
METLEN Energy & Metals: 2025 Financial Results (PR Newswire)
|
|
|
ATHENS, Greece and LONDON, April 9, 2026 /PRNewswire/ -- METLEN Energy & Metals PLC (LSE Listing: MTLN, RIC: MTLN.L, Bloomberg: MTLN.LN | Athens Listing: MTLN, RIC: MTLNr.AT, Bloomberg: MTLN.GA, ADR: MYTHY US) today announces the FY 2025 results. Revenue rose to €7,107 million, up 25%......
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
